NF-KB | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

388 results for “NF-KB”

Trials

View all 104 →

The Induction of IL-6 by NF-kB in PBMC in OSA

20 participants · First posted Jul 10, 2007

Effects of Physical Activities on the Expression of Nrf2 and Nf-kb Hemodialysis Patients

40 participants · First posted Mar 24, 2016

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

First posted Jan 4, 2011

Drugs

View all 156 →

Investigational

NF-kappaB Decoy

ART-I02

NF-kB inhibitor (Henan University)

Organizations

KB Financial Group Inc.

South Korea

Depo NF Sub, LLC

United States

宁夏紫荆花药业股份有限公司

News

View all 125 →

Primmune Therapeutics Raises $8.6M to Advance TLR7 Agonist PRTX007 into Phase 2 Melanoma Trial

Curis Opens Eleven Clinical Sites for Phase 2 TakeAim CLL Study of Emavusertib–Zanubrutinib Combination

Tivic Health Advances Entolimod Development with Two FDA Investigational New Drug Applications

Page 1 of 39